Transit-Pellets® Radiopaque Markers

  • FDA 510(k) clearance for use in adult patients
  • FDA 510(k) clearance for use in pediatric patients (≥2 y/o)
  • CE marked (for use in adult patients)
  • Encapsulated colon transit markers
  • Capsules purely vegetarian
  • Easy to administer
  • Manufactured in Sweden

Transit-Pellets Description

The Transit-Pellets device is specially designed and packaged for ease of use in accordance with the Transit-Pellets method. Each box includes seven capsules that are to be taken in coordination over a six-day period, as per the Transit-Pellets method. To be dispensed only by physicians to patients for oral intake.

Order Information
DescriptionUnit of MeasureQuantity
Transit-PelletsPackEach pack contains 10 boxes. Each box is for single patient use.
Primary PackagingSecondary Packaging
The blister pack is labeled with numbers 1 through 6. The markings 6:1 and 6:2 on the back of the blister pack correspond to the morning and evening doses for the sixth day respectively.The dimensions of the Transit-Pellets box containing the blister pack are 8.0cm x 2.0cm x 11.0cm. Each box includes a Transit-Pellets package insert translated into nearly 20 languages.
Physical Properties
Transit-Pellets radiopaque markersThe radiopaque markers are composed of 78% Elastosil ® R 401/60 Silicone Rubber and 22% Barium Sulphate. Each box of Transit-Pellets contains 50 ring-formed markers measuring 2×4.5mm* and 10 tube formed markers measuring 6x2mm*.
HPMC CapsulesThe Hydroxypropyl methylcellulose (HPMC) capsules, size -00-, made from wood cellulose, have no odor or taste, contain no preservatives or allergens.

* +/- 0.15mm

Operational Properties
Storage TemperatureStored at normal room temperature.
Shelf LifeNot to be used beyond the expire date indicated on the package.
DisposalUnused Transit-Pellets do not require any special disposal measures and can be safely disposed of with regular household waste. The packaging can also be recycled as per the local regulations.
Indication, Safety, and Warnings
Clinical Instructions for Use Clinical Instructions for Use
To access other translations of our Clinical Instructions for Use, please click here.